Mark Dunnenberger, PharmD
Pharmacogenomics (PGx) can play an important role in pain management because PGx can increase the likelihood of opioid efficacy and potentially limit the risk for misuse, among other advantages.
“Genotyping alone is not a silver bullet for the opioid crisis, but it adds a useful bit of information to help build a comprehensive pain management plan that effectively treats a patient’s pain,” said Mark Dunnenberger, PharmD, the director of